Latency of potential treatment-related adverse events among patients treated with TKI/VEGF-directed therapy for metastatic renal cell carcinoma (mRCC) Conference

Gong, Jun, George, Daniel, Wallen, Herschel et al. (2016). Latency of potential treatment-related adverse events among patients treated with TKI/VEGF-directed therapy for metastatic renal cell carcinoma (mRCC) . BJU INTERNATIONAL, 118 9-9.

Industry Collaboration

cited authors

  • Gong, Jun; George, Daniel; Wallen, Herschel; Mhatre, Shivani; Lin, Shih-Wen; Ogale, Sarika; Vohra, Rini; Surinach, Andy; Simpson, Joe; Pal, Sumanta

authors

date/time interval

  • November 4, 2016 -

publication date

  • December 1, 2016

published in

keywords

  • Life Sciences & Biomedicine
  • Science & Technology
  • Urology & Nephrology

Location

  • FL, Miami

Conference

  • 15th International Kidney Cancer Symposium

publisher

  • WILEY-BLACKWELL

start page

  • 9

end page

  • 9

volume

  • 118